OSIRIS THERAPEUTICS (OSIR)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on OSIRIS THERAPEUTICS (OSIR)
28 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on OSIR
- Mike Havrilla(8)
- TickerSense (4)
- Centient Biotech Investor(4)
- Herb Greenberg(3)
- H.S. Ayoub(2)
Most popular authors
(tracked in watchlists)
- SA Editor Eli Hoffmann(412)
- Mike Havrilla(161)
- Mike Huckman(75)
- John Lee(53)
- TickerSense (49)
Most commented on authors
- Ketan Desai (13)
- Mike Havrilla(13)
- John Lee(5)
- SA Editor Eli Hoffmann(5)
- Laura Cadden(4)
- Stem Cell and Regenerative Medicine Stocks Surge in December
- Healthcare: Investing Trends for 2009
- Cytori Therapeutics and Cypress Bio: Two Buys Based on Positive Trial Results
- ETF Ideas Poised to Benefit from Pending Healthcare Reform
- New Emerging Biotech and Pharma Company Index
- Regenerative Medicine: Big Pharma's Next Frontier
- ETFI Global Healthcare Sector PerfomIdex
- Genzyme and Osiris Get Together on Stem Cells
- Cosmetic and Reconstructive Medicine ETF Outpaces Healthcare Sector
- Three Biotechs Hitting New 52-Week Highs
- 10 Biotechs in Stem Cells that Could Profit Under the Democrats
- Osiris Therapeutics: Bone Regeneration = Big Bucks
- How to Profit from Stem Cell R&D - Barron's
- Osiris: Positive Heart Drug Data Boosts Stock
- Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
- Biotech Week In Review: Recovering Some Lost Ground
- Russell 3000's Best and Worst Stocks, Week and Year to Date
- Russell 3000's Best and Worst Stocks, Week and Year to Date
- Osiris: Promising Stem Cell Research, Risky Management
- Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
- Osiris: Knee Replacement Drug A Bust
- Best Stem Cell Plays: Osiris and Aastrom
- 2007: The Year Of Biotech IPOs?
- Russell 3000's Best Performing Stocks of 2006
- Osiris: Good News (But A Few People Died)
- Russell 3000's Best and Worst Performing Stocks
- Hematology Meeting to Boost Amgen, Biogen Idec and Other Biotechs
- This Week's IPOs: Asset Capital, Buckeye GP Holdings, Osiris Therapeutics, Security Capital Assurance
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »